245 related articles for article (PubMed ID: 31370220)
1. Gut Dysbiosis and the Intestinal Microbiome:
Vitetta L; Llewellyn H; Oldfield D
Microorganisms; 2019 Jul; 7(8):. PubMed ID: 31370220
[TBL] [Abstract][Full Text] [Related]
2. From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling.
Vitetta L; Linnane AW; Gobe GC
Toxins (Basel); 2013 Nov; 5(11):2042-57. PubMed ID: 24212182
[TBL] [Abstract][Full Text] [Related]
3. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
[TBL] [Abstract][Full Text] [Related]
4. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins.
Lau WL; Savoj J; Nakata MB; Vaziri ND
Clin Sci (Lond); 2018 Mar; 132(5):509-522. PubMed ID: 29523750
[TBL] [Abstract][Full Text] [Related]
5. Intestinal barrier disruption and dysregulated mucosal immunity contribute to kidney fibrosis in chronic kidney disease.
Yang J; Lim SY; Ko YS; Lee HY; Oh SW; Kim MG; Cho WY; Jo SK
Nephrol Dial Transplant; 2019 Mar; 34(3):419-428. PubMed ID: 29939312
[TBL] [Abstract][Full Text] [Related]
6. The role of adjuvant probiotics to attenuate intestinal inflammatory responses due to cancer treatments.
Thomsen M; Clarke S; Vitetta L
Benef Microbes; 2018 Dec; 9(6):899-916. PubMed ID: 30232908
[TBL] [Abstract][Full Text] [Related]
7. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
Briskey D; Tucker P; Johnson DW; Coombes JS
Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
[TBL] [Abstract][Full Text] [Related]
8. Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease.
Glorieux G; Gryp T; Perna A
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32290429
[TBL] [Abstract][Full Text] [Related]
9. Preventive Effects of
Huang H; Li K; Lee Y; Chen M
J Agric Food Chem; 2021 Jul; 69(26):7353-7366. PubMed ID: 34170659
[TBL] [Abstract][Full Text] [Related]
10. Probiotics and Probiotic-Derived Functional Factors-Mechanistic Insights Into Applications for Intestinal Homeostasis.
Yan F; Polk DB
Front Immunol; 2020; 11():1428. PubMed ID: 32719681
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota in chronic kidney disease.
Cigarran Guldris S; González Parra E; Cases Amenós A
Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
[TBL] [Abstract][Full Text] [Related]
12. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
[TBL] [Abstract][Full Text] [Related]
13. Biotics (Pre-, Pro-, Post-) and Uremic Toxicity: Implications, Mechanisms, and Possible Therapies.
Mitrea L; Medeleanu M; Pop CR; Rotar AM; Vodnar DC
Toxins (Basel); 2023 Sep; 15(9):. PubMed ID: 37755974
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiome in Chronic Kidney Disease.
Armani RG; Ramezani A; Yasir A; Sharama S; Canziani MEF; Raj DS
Curr Hypertens Rep; 2017 Apr; 19(4):29. PubMed ID: 28343357
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the capability of a gelling complex made of tara gum and the exopolysaccharides produced by the microorganism Streptococcus thermophilus ST10 to prospectively restore the gut physiological barrier: a pilot study.
Del Piano M; Balzarini M; Carmagnola S; Pagliarulo M; Tari R; Nicola S; Deidda F; Pane M
J Clin Gastroenterol; 2014; 48 Suppl 1():S56-61. PubMed ID: 25291130
[TBL] [Abstract][Full Text] [Related]
16. The Human Microbiome in Chronic Kidney Disease: A Double-Edged Sword.
Wehedy E; Shatat IF; Al Khodor S
Front Med (Lausanne); 2021; 8():790783. PubMed ID: 35111779
[TBL] [Abstract][Full Text] [Related]
17. The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.
Ekmekciu I; von Klitzing E; Fiebiger U; Neumann C; Bacher P; Scheffold A; Bereswill S; Heimesaat MM
Front Cell Infect Microbiol; 2017; 7():167. PubMed ID: 28529928
[TBL] [Abstract][Full Text] [Related]
18. Probiotics and chronic kidney disease.
Koppe L; Mafra D; Fouque D
Kidney Int; 2015 Nov; 88(5):958-66. PubMed ID: 26376131
[TBL] [Abstract][Full Text] [Related]
19. Uremia and chronic kidney disease: the role of the gut microflora and therapies with pro- and prebiotics.
Vitetta L; Gobe G
Mol Nutr Food Res; 2013 May; 57(5):824-32. PubMed ID: 23450842
[TBL] [Abstract][Full Text] [Related]
20. Microbiota and prebiotics modulation of uremic toxin generation.
Koppe L; Fouque D
Panminerva Med; 2017 Jun; 59(2):173-187. PubMed ID: 28001024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
